Portugal
Influenza. Bastonary of pharmacists calls for vaccination
Publication: Observador - Últimas
Author: Agência Lusa
Source published: 30/09/2026, 06:28:38 UTC
Briefing created: 30/09/2026, 06:34:39 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 30/09/2026, 06:31:24 UTC.
Briefings
In September 2026, the SNS pharmaceutical company reported a significant increase in its annual vaccine procurement, purchasing approximately 2.3 million doses of standard influenza vaccines and 369,000 doses of high-dose vaccines. This represents a rise of 187,000 standard doses and 12,000 high-dose vaccines compared to the previous year. The data reflects a substantial shift in inventory strategy for the Brazilian public health system.
Key points
- The SNS pharmaceutical company purchased approximately 2.3 million doses of standard influenza vaccines and 369,000 doses of high-dose vaccines in 2026, representing a 187,000 increase in standard doses and 12,000 in high-dose vaccines.
- The reported increase in high-dose vaccine purchases by SNS in 2026 suggests a strategic shift toward prioritizing high-dose formulations for the Brazilian public health system.
Context and limitations
The evidence covers only the annual procurement figures for 2026, with no details on specific distribution targets, regional allocation, or the reasons behind the 187,000 increase in standard doses.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/09/2026, 06:34:39 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeih4vqc7isqmqd6x653k2crlqq52lo3n2i6hoyzlu4tagpwfyj4aju